ArticleFrontiers in genetics2019

A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide.

Rui-Chao Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.